Plaque Modification Devices Market to Reach US$1.94 Billion by 2030, Growing at 8.2% CAGR | North America Leads with Advanced Cardiovascular Care Infrastructure | DataM Intelligence

Leander, Texas and Tokyo, Japan - Dec 01, 2025
According to DataM Intelligence, the plaque modification devices market, valued at US$1.12 billion in 2023, is projected to reach approximately US$1.94 billion by 2030 at a CAGR of 8.2%. This robust growth is propelled by increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive procedures, growing elderly population with atherosclerosis, technological advancements in plaque modification, and expanding applications in complex coronary and peripheral artery interventions.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/plaque-modification-devices-market?jd

Report Details:
• No. of Pages: 180
• Forecast Period: 2023-2030
• Estimated Market Value (USD) in 2023: $1.12 Billion
• Forecasted Market Value (USD) by 2030: $1.94 Billion
• Compound Annual Growth Rate: 8.2%
• Regions Covered: Global

United States Recent Developments:
✅ Boston Scientific launched next-generation orbital atherectomy systems with enhanced tissue differentiation for calcified plaque modification
✅ Medtronic received FDA clearance for their latest directional atherectomy platform with improved debris management capabilities
✅ Abbott Laboratories introduced laser atherectomy devices with real-time optical coherence tomography guidance for precise plaque removal

Japan Recent Developments:
✅ Terumo Corporation developed specialized rotational atherectomy systems optimized for smaller vessel diameters in Asian populations
✅ Japan's PMDA approved novel plaque modification catheters with integrated imaging for complex coronary interventions
✅ NIPRO Medical introduced cost-effective atherectomy solutions for emerging Asian cardiovascular markets

Buy Now and Enjoy a 30% Year-End Discount: https://www.datamintelligence.com/buy-now-page?report=plaque-modification-devices-market

Competitive Landscape
The market features intense competition between global medical device companies, specialized cardiovascular technology providers, and interventional equipment manufacturers.

1. Boston Scientific Corporation maintained market leadership with 28% global market share, expanding their orbital atherectomy portfolio and reporting 30% revenue growth in 2024-2025 through hospital partnerships.
2. Medtronic plc captured 25% market share in directional atherectomy, securing long-term contracts with cath labs and achieving 28% growth through integrated solutions.
3. Abbott Laboratories dominated the laser atherectomy segment with 22% market share, reporting 32% growth through advanced imaging integration.
4. Terumo Corporation led Asian market expansion with 18% market share, achieving 26% growth through specialized devices for regional anatomical requirements.
5. Philips Healthcare expanded their intravascular imaging guidance systems with 15% market share, focusing on procedural optimization with 24% revenue growth.

Speak to Our Analyst and Get Customization in the Report: https://www.datamintelligence.com/customize/plaque-modification-devices-market?jd

Segmentation Analysis
By Device Type
• Atherectomy devices are expected to hold a significant share during the forecasted period with 45% revenue share in 2024, projected to grow at 9.2% CAGR, valued for direct plaque removal capabilities, effectiveness in calcified lesions, vessel preparation for stenting, and essential role in complex percutaneous coronary interventions requiring debulking of challenging atherosclerotic plaques.
• Thrombectomy devices shows strong growth with 30% revenue share in 2024, expected to grow at 7.8% CAGR, preferred for acute coronary syndromes and fresh thrombus removal.
• Cutting and scoring balloons demonstrates significant expansion with 25% revenue share in 2024 for lesion preparation and controlled balloon expansion.

Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription?jd

Regional Analysis:
North America holds the largest market share with 46% revenue share in 2024, driven by advanced cardiovascular care infrastructure, high procedure volumes, favorable reimbursement policies, strong physician adoption of innovative technologies, and significant research and development investments across the United States and Canada.

Asia-Pacific emerges as the fastest-growing region, projected to expand at 10.5% CAGR through 2030, fueled by improving healthcare access, rising cardiovascular disease burden, growing interventional cardiology capabilities, increasing medical tourism, and expanding healthcare investments across China, Japan, India, and Southeast Asian countries.

Market Trends & Drivers
The Plaque Modification Devices Market is experiencing robust growth driven by interventional cardiology advancement, complex lesion treatment needs, technological innovation, and patient outcome focus. Key trends include the development of combination devices, growth of imaging-guided procedures, advancement in debulking technologies, expansion of peripheral artery applications, and increasing focus on vessel preparation optimization. The interventional evolution, technological convergence, and procedural optimization are significantly contributing to market growth.

Related Reports:
1. Coronary Stents Market - https://www.datamintelligence.com/research-report/coronary-stents-market?jd
2. Peripheral Vascular Devices Market - https://www.datamintelligence.com/research-report/peripheral-vascular-devices-market?jd
3. Interventional Cardiology Market - https://www.datamintelligence.com/research-report/interventional-cardiology-market?jd

Contact Us:
Sai Kiran
DataM Intelligence 4market Research LLP
Phone: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specialises in strategic reports that guide businesses in high-growth sectors such as nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.